ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 944

$546K Total Retail Price of All Prescriptions

Rank: 167 out of 944

378 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 378 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 569 493 1 2
FUROSEMIDE 347 303 2 6
HYDROCODONE-ACETAMINOPHEN 339 235 S3 3 10
SIMVASTATIN 299 254 4 1
AMLODIPINE BESYLATE 261 228 5 5
OMEPRAZOLE 249 193 6 4
METOPROLOL TARTRATE 248 228 7 8
WARFARIN SODIUM 233 207 8 7
LISINOPRIL 229 190 9 3
GABAPENTIN 199 142 10 18
METFORMIN HCL 179 157 11 12
POTASSIUM CHLORIDE 155 130 12 15
METOPROLOL SUCCINATE 153 136 13 14
NAMENDA 133 132 14 37
ZOLPIDEM TARTRATE 129 83 15 25
LOVASTATIN 128 85 16 26
POLYETHYLENE GLYCOL 3350 125 119 17 41
ATENOLOL 125 110 17 11
IPRATROPIUM-ALBUTEROL 124 123 19 101
ADVAIR DISKUS 120 112 20 31
HYDROCHLOROTHIAZIDE 114 102 21 9
OXYCODONE HCL 108 50 S2 22 50
ATORVASTATIN CALCIUM 98 85 23 13
CITALOPRAM HBR 95 78 24 19
RANITIDINE HCL 95 81 24 42
ALLOPURINOL 94 88 26 22
PREDNISONE 92 86 27 32
ALENDRONATE SODIUM 92 80 27 20
DOXAZOSIN MESYLATE 87 80 29 60
TRAZODONE HCL 84 53 30 45
DIOVAN 84 61 30 38
PANTOPRAZOLE SODIUM 81 66 32 34
DONEPEZIL HCL 79 79 33 24
SERTRALINE HCL 78 40 34 23
FLUOXETINE HCL 78 64 34 48
JANUVIA 77 73 36 81
DIGOXIN 74 61 37 39
LOSARTAN POTASSIUM 72 69 38 16
FENTANYL 69 38 S2 39 57
OXYCODONE-ACETAMINOPHEN 69 41 S2 39 62
CARBIDOPA-LEVODOPA 68 52 41 77
TAMSULOSIN HCL 61 53 42 27
GLIPIZIDE XL 58 58 43 136
KLOR-CON 10 57 46 44 115
KLOR-CON M20 56 44 45 71
CRESTOR 55 47 46 28
TRAMADOL HCL 54 48 47 21
MORPHINE SULFATE ER 54 30 S2 47 80
GLIMEPIRIDE 50 50 49 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.